UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The South Texas Health Status Review: A Health Disparities Roadmap

2013 edition., 2013

Volltextzugriff (PDF)

The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial

PloS one, 2018-10, Vol.13 (10), p.e0204823

2018

Volltextzugriff (PDF)

5α-Reductase Inhibitor Use in Patients With Prostate Cancer

JAMA internal medicine, 2019-10, Vol.179 (10), p.1440

2019

Volltextzugriff (PDF)

MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study

PloS one, 2016-11, Vol.11 (11), p.e0165236-e0165236

2016

Volltextzugriff (PDF)

Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients

PloS one, 2015-07, Vol.10 (7), p.e0132343-e0132343

2015

Volltextzugriff (PDF)

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence

PloS one, 2012-09, Vol.7 (9), p.e44917

2012

Volltextzugriff (PDF)

Focal therapy of prostate cancer-the challenge

Oncology (Williston Park, N.Y.), 2013, Vol.27 (1), p.70

Thompson, Jr, Ian M

2013

Volltextzugriff (PDF)

Evolving Recommendations on Prostate Cancer Screening

American Society of Clinical Oncology educational book, 2016, Vol.36 (36), p.e80-e87

2016

Volltextzugriff (PDF)

Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer

Oncotarget, 2023-10, Vol.14 (1), p.890-892

2023

Volltextzugriff (PDF)

Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer

Oncotarget, 2023-06, Vol.14 (1), p.622-636

2023

Volltextzugriff (PDF)

Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators

Journal of biomedical informatics, 2015-08, Vol.56, p.87-93

2015

Volltextzugriff (PDF)

Adjuvant radiotherapy for high-risk patients following radical prostatectomy

Urologic oncology, 2007-11, Vol.25 (6), p.515-519

2007

Volltextzugriff (PDF)

Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis

Scientific reports, 2016-02, Vol.6 (1), p.22051-22051, Article 22051

2016

Volltextzugriff (PDF)

Provider and partner interactions in the treatment decision‐making process for newly diagnosed localized prostate cancer

BJU international, 2011-09, Vol.108 (6), p.851-856

2011

Volltextzugriff (PDF)

Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer

Oncotarget, 2018-01, Vol.9 (5), p.6550-6561

2018

Volltextzugriff (PDF)

EVALUATING THE ROLE OF DIABETES AND THE DIABETES RELATED GENE, TCF2, IN PROSTATE CANCER RISK AMONG AFRICAN-AMERICAN, CAUCASIAN, AND HISPANIC MEN

The Journal of urology, 2009, Vol.181 (4), p.206-206

2009

Volltextzugriff (PDF)

PSA: A Biomarker for Disease. A Biomarker for Clinical Trials. How Useful Is It?

The Journal of nutrition, 2006-10, Vol.136 (10), p.2704S-2704S

Thompson, Ian M

2006

Volltextzugriff (PDF)

MP21-12 PCA3 AND T2:ERG ADD FURTHER PREDICTIVE AND CLINICAL BENEFIT TO THE DETECTION OF PROSTATE CANCER IN MEN OF VARIOUS AGES IN THE EARLY DETECTION RESEARCH NETWORK (EDRN)

The Journal of urology, 2016-04, Vol.195 (4), p.e249-e250

2016

Volltextzugriff (PDF)

Editorial Comment on adjuvant radiotherapy study

Urology (Ridgewood, N.J.), 2008-12, Vol.72 (6), p.1303-1304

Thompson, Ian M

2008

Volltextzugriff (PDF)

MP64-05 SELF-REPORTED FINASTERIDE USE IS ASSOCIATED WITH DECREASED INCIDENCE OF BLADDER CANCER: DATA FROM THE PROSTATE, LUNG, COLORECTAL, & OVARIAN CANCER STUDY

The Journal of urology, 2015-04, Vol.193 (4), p.e799-e799

2015

Volltextzugriff (PDF)

Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification

Archivio italiano di urologia, andrologia, 2006-12, Vol.78 (4), p.125

2006

Volltextzugriff (PDF)

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

Cancer causes & control, 2011-08, Vol.22 (8), p.1121-1131

2011

Volltextzugriff (PDF)

1 – 25 von 1.141

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.008)
Mit Volltextzugriff
(860)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(247)
Humans
(177)
Physical Sciences
(150)
Male
(114)
Biological And Medical Sciences
(101)
Medical Sciences
(88)
Science & Technology - Other Topics
(77)
Multidisciplinary Sciences
(75)
Nephrology. Urinary Tract Diseases
(57)
Female
(55)
Physics
(55)
Tumors
(51)
Chemistry
(49)
Tumors Of The Urinary System
(48)
Urinary Tract. Prostate Gland
(47)
Adult
(45)
Middle Aged
(45)
Prostate Cancer
(44)
Astronomy & Astrophysics
(43)
Technology
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(119)
Journal Of Clinical Oncology
(68)
Urology
(38)
Plos One
(34)
The Astrophysical Journal
(20)
Nature Communications
(19)
Cancer Research
(17)
Nature
(12)
Proceedings Of The National Academy Of Sciences - Pnas
(12)
The Astronomical Journal
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

The South Texas Health Status Review: A Health Disparities Roadmap

The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial

5α-Reductase Inhibitor Use in Patients With Prostate Cancer

Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial

MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study

Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence

Focal therapy of prostate cancer-the challenge

Evolving Recommendations on Prostate Cancer Screening

Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma

Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer

Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer

Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators

Adjuvant radiotherapy for high-risk patients following radical prostatectomy

Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis

Provider and partner interactions in the treatment decision‐making process for newly diagnosed localized prostate cancer

Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer

EVALUATING THE ROLE OF DIABETES AND THE DIABETES RELATED GENE, TCF2, IN PROSTATE CANCER RISK AMONG AFRICAN-AMERICAN, CAUCASIAN, AND HISPANIC MEN

Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

PSA: A Biomarker for Disease. A Biomarker for Clinical Trials. How Useful Is It?

MP21-12 PCA3 AND T2:ERG ADD FURTHER PREDICTIVE AND CLINICAL BENEFIT TO THE DETECTION OF PROSTATE CANCER IN MEN OF VARIOUS AGES IN THE EARLY DETECTION RESEARCH NETWORK (EDRN)

Editorial Comment on adjuvant radiotherapy study

MP64-05 SELF-REPORTED FINASTERIDE USE IS ASSOCIATED WITH DECREASED INCIDENCE OF BLADDER CANCER: DATA FROM THE PROSTATE, LUNG, COLORECTAL, & OVARIAN CANCER STUDY

Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

Aktive Filter

Suchergebnisse filtern